Last $44.54 USD
Change Today +0.56 / 1.27%
Volume 3.7M
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard S. Levy M.D.

Chief Drug Development & Medical Officer and Executive Vice President, Incyte Corporation
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 2 different industries.

See Board Relationships
55$1,345,410
As of Fiscal Year 2012

Background*

Dr. Richard S. Levy, M.D. has been the Chief Drug Development Officer & Medical Officer and Executive Vice President of Incyte Corporation since January 2009. Dr. Levy served as the Senior Vice President of Drug Development of Incyte Corporation since August 26, 2003. He has over 12 years of experience in the pharmaceutical and biotechnology sectors through his prior positions at Celgene, DuPont Pharmaceuticals and Novartis. Most recently, he served as Vice President ...

Read Full Background

Corporate Headquarters*

Experimental Station
Wilmington, Delaware 19880

United States

Phone: 302-498-6700
Fax: --

Board Members Memberships*

2014-Present
Director

Education*

MD
The University of Pennsylvania
BA
Brown University

Other Affiliations*

Annual Compensation*

Salary$354,602
Total Annual Compensation$354,602

Stock Options*

All Other Compensation$6,569
Exercised Options30,000
Exercised Options Value$425,552
Exercisable Options489,549
Exercisable Options Value$3,753,787
Unexercisable Options138,891
Unexercisable Options Value$87,011
Total Value of Options$4,266,349
Total Number of Options658,440

Total Compensation*

Total Annual Cash Compensation$573,932
Total Short Term Compensation$354,602
Other Long Term Compensation$6,569
Total Calculated Compensation$1,345,410
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $44.54 USD +0.56

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman of the Board, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$1.7M
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Werner Lanthaler MBA/MPAChief Executive Officer
Evotec AG
€601.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.